Capital International Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.4M | Buy |
71,831
+4,870
| +7% | +$1.59M | 0.23% | 118 |
|
|
2025
Q1 | $18.1M | Sell |
66,961
-38,124
| -36% | -$10.3M | 0.22% | 125 |
|
|
2024
Q4 | $24.7M | Sell |
105,085
-20,136
| -16% | -$4.74M | 0.29% | 98 |
|
|
2024
Q3 | $34.4M | Buy |
125,221
+11,237
| +10% | +$3.09M | 0.43% | 65 |
|
|
2024
Q2 | $27.7M | Buy |
113,984
+20,608
| +22% | +$5.01M | 0.37% | 77 |
|
|
2024
Q1 | $14M | Sell |
93,376
-6,646
| -7% | -$993K | 0.19% | 139 |
|
|
2023
Q4 | $19.1M | Buy |
100,022
+3,549
| +4% | +$679K | 0.3% | 103 |
|
|
2023
Q3 | $17.1M | Buy |
96,473
+38,626
| +67% | +$6.84M | 0.33% | 93 |
|
|
2023
Q2 | $11M | Buy |
57,847
+6,555
| +13% | +$1.25M | 0.2% | 137 |
|
|
2023
Q1 | $10.3M | Buy |
51,292
+4,082
| +9% | +$818K | 0.21% | 125 |
|
|
2022
Q4 | $11.2M | Buy |
47,210
+8,148
| +21% | +$1.94M | 0.24% | 118 |
|
|
2022
Q3 | $7.82M | Sell |
39,062
-3,101
| -7% | -$621K | 0.17% | 134 |
|
|
2022
Q2 | $6.15M | Buy |
42,163
+22,773
| +117% | +$3.32M | 0.09% | 170 |
|
|
2022
Q1 | $3.17M | Buy |
+19,390
| New | +$3.17M | 0.04% | 205 |
|